Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysisScott Goldsmith, Marcie Riches, Muhammad Bilal Abid et al.|Blood|2021Cited by 177
Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant ResearchMichelle Long Schoettler, Sumithira Vasu, Paul A. Carpenter et al.|Transplantation and Cellular Therapy|2022Cited by 130
Updated Trends in Hematopoietic Cell Transplantation in the United States with an Additional Focus on Adolescent and Young Adult Transplantation Activity and OutcomesRachel Phelan, Mukta Arora, Min Chen et al.|Transplantation and Cellular Therapy|2022Cited by 82
Real-World Data Showing Trends and Outcomes by Race and Ethnicity in Allogeneic Hematopoietic Cell Transplantation: A Report from the Center for International Blood and Marrow Transplant ResearchJeffery J. Auletta, Bronwen E. Shaw, Jianqun Kou et al.|Transplantation and Cellular Therapy|2023Cited by 68
Current Trends and Outcomes in Cellular Therapy Activity in the United States, Including Prospective Patient-Reported Outcomes Data Collection in the Center for International Blood and Marrow Transplant Research RegistryRachel Cusatis, Bronwen E. Shaw, Carlos Litovich et al.|Transplantation and Cellular Therapy|2024Cited by 68